Form 4 for IMDX Insight Molecular Diagnostics Inc.
Accepted 2022-03-16 00:00:00 ET · period of report 2022-03-16 · accession 0001493152-22-007054 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-16 | 2022-03-16 | IMDX | Redmond Cavan M. | Dir | P - Purchase | $1.19 | +40.0K | 110.9K | +56% | +$47.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, no par value | 2022-03-16 | P | A | 40,000 | $1.19 | 110,863 | D | — | — |